CompoAtlas

iClariVis Eyebright Complex Chewable Tablet Vanilla Flavour

iClariVis Eyebright Complex Chewable Tablet Vanilla Flavour : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Registration number
MAL25096153TC
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
SYRA ZENITH SDN. BHD.
Manufacturer
I MEDIKEL PHARMACEUTICAL SDN. BHD.
Registration period starting
2025-09-08
Published validity end
2030-09-08

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Euphrasia officinalisEuphrasia officinalis[350 mg,1000 mg]Not identified
Vaccinium angustifoliumVaccinium angustifolium[20 mg,1000 mg]Not identified
Tagetes erectaTagetes erecta[4 mg,1000 mg]Not identified
Haematococcus pluvialisHaematococcus pluvialis[0.4 mg,1000 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Active ingredients
Euphrasia officinalis[350 mg,1000 mg],Vaccinium angustifolium[20 mg,1000 mg],Tagetes erecta[4 mg,1000 mg],Haematococcus pluvialis[0.4 mg,1000 mg]
Valid until
2030-09-08
Registration date
2025-09-08
Published description
NATURAL PRODUCT
Licence holder
SYRA ZENITH SDN. BHD.
Producer
I MEDIKEL PHARMACEUTICAL SDN. BHD.
Published name
iClariVis Eyebright Complex Chewable Tablet Vanilla Flavour
Published reference
2025031317901T
Registration number
MAL25096153TC
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL25096153TC

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vaccinium angustifolium
    Read the warning, when it applies and the studies cited

    Blueberry

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing 5 grams or more of total dried fruit, per day; Products providing 37.5 grams or more of total fresh fruit, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (ASHP 2005; Franco et al. 2004; IOM 2001; Hansten et al. 1997).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 August 2025

  • Haematococcus pluvialis
    Read the warning, when it applies and the studies cited

    Haematococcus pluvialis extract

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Eye strain, Eye fatigue.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 10 January 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line